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To the Editor,
Exercise-induced bronchoconstriction (EIB) is highly prevalent in children and adults with asthma, and 
elite athletes. There isstrong evidence to support that bronchial provocation tests that act indirectly are 
essentialto obtain an accurate diagnosisof the condition.1  Despite these recommendations, people with 
respiratory symptoms on exertion are regularly diagnosed with EIBbased on symptoms alone and treated 
in primary care.2In secondary care, debate remains regarding the optimal diagnostic protocol.3Further, it 
is unclear which diagnostic tests are commonly utilized and, importantly, the extent to which practitioners 
adhere to bronchial provocation guidelines in secondary care.
In this survey of diagnostic practice in secondary care, we aim to identify current indirect bronchial 
provocation challenges in use across the United Kingdom for the diagnosis of EIB and, where applicable, 
assess adherenceto exercise bronchial provocation guidelines.
Methods 
We conducted a survey of EIB diagnostic practices in hospitals with respiratory physiology laboratories, 
identified through the Association for Respiratory Technology and Physiology (ARTP). Forty-three 
hospitals were identified and approached via e-mail and/or phone. Details of the first-line indirect 
bronchial provocation test and standard operating procedures (SOP) for exercise challenge tests were 
requested. SOPs were subsequently examined for adherence to five criteria specified in the American 
Thoracic Societyexercise bronchialprovocation guidelines,1,4as detailed in Table 1.Data regarding EIB 
diagnosis thresholds for exercise provocation testing were also obtained. 
Results
Forty of 43 centers responded; 29 (73%) of these stated that they offeredone or more indirect bronchial 
provocation test for the diagnosis of EIB. As a first line diagnostic test, 48% of respondents conducted 
mannitol challenges, 45% exercise provocation challenges, 3% cardiopulmonary exercise testing and 3% 
histamine challenge testing. 
Exercise bronchial provocation SOPs were provided by nine centers (21%) and their adherence to ATS 
guidelines assessed.All nine SOPs referred to measuring exercise intensity via heart rate at an appropriate 
intensity and all but one (89%) followed the guidance on exercise duration (figure 1). Spirometry timings 
did not follow ATS criteria in 67% of SOPs (figure 1). Importantly,only two of the SOPs (22%) 
includedguidance on appropriate environmental conditions (figure 1). No centerprovided details sufficient A
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to indicate full adherence to medication restrictions were routinely implemented in the SOPs; the authors 
were therefore unable ascertain with any certainty whether medication restrictions were considered. The 
criterion for EIB diagnosis varied between centers; 56% specified a fall in FEV1 of ≥10%, with the remaining 
SOPs stating a ≥15% fall in FEV1 as the threshold for diagnosis following exercise provocation. 
Discussion 
Due to the poor sensitivity and specificity of respiratory symptoms to diagnose EIB,5an indirect bronchial 
provocation challenge is recommended.1Strong evidence suggests that the prevalence of EIB will vary 
with the type of challenge and the conditions under which the challenge is performed.1,3Thus, strict 
adherence to provocation guidelines is essential if results are to be valid and comparable across centers. 
Here, we report that mannitol andbronchial provocation with exercise are utilized in the vast majority of 
UK hospitals for the diagnosis of EIB; both of which are considered appropriate for the diagnosis of the 
condition.1Interestingly, eucapnic voluntary hyperpnoea, which is often referred to as the ‘gold standard’ 
for the diagnosis of the condition in athletes, was not utilized by any of the participating centers. 
Adherence to mannitol provocation guidelines was not considered further,due tothe nature of this 
bronchial provocation challenge being typically well standardized.
The lack of standardization for exercise challenge testing however is of concern.  Many variables including 
exercise intensity, duration, humidity, temperature and time since medication will affect the airway 
response to exercise in individuals with EIB.6Of these factors, our data suggest that medication 
restrictions were often not detailed and environmental conditions (i.e., temperature and humidity of 
inspired air) were rarely considered in the SOPs. As the inhalation of dry air is the main contributing factor 
in the pathophysiology of EIB,7lack of consideration of this variable will undoubtedlyresult in missed-
diagnoses.Recommendations to overcome this problem include the use of an environmental chamber, 
whichcan reduce and control the temperature and humidity of inspired air.However this method is often 
limited to research facilities or sport science departments.Or,more practical for a hospital setting, the 
inhalation of medical grade air which is dry.4 Crucially, our data indicated that these recommendations are 
scarcely adhered to in clinical practice. As data were retrieved directly from the SOPs provided, we do not 
foresee any problems with recall bias in the study, however we acknowledge a risk of non-response bias 
in the sample. 
The problem of poor standardization of exercise challenge testing goes beyond clinical practice and may 
affect the diagnostic guidelines themselves. Indeed, previous research suggest that environmental A
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conditions are rarely reported or considered in diagnostic studies for EIB,8even those used to inform 
clinical guidelines. For example,NICE guidelines on asthma diagnosis, monitoring and management state 
that exercise challenge tests should not be used for the diagnosis of asthma in persons aged 17 and 
over;9a recommendation based on findings from five studies. It is therefore highly likely that inferences 
from poorly performed exercise provocation challenges are informing clinical guidelines. 
To conclude, our data show thatpoor adherence to exercise bronchial provocation guidelines is 
commonplace in secondary care.The consequence is potentially widespread under-detection of EIB. More 
effort must be made to educate practitioners in the importance of controlling environmental conditions 
and ensure strict adherence to exercise provocation guidelines. Where adherence to the environmental 
criteria are not feasible, a surrogate indirect bronchial provocation challenge (e.g., mannitol, eucapnic 
voluntary hyperpnoea) should be performed.  
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Table 1. Exercise bronchial provocation specifications from exercise challenge testing guidelines1,4 
Guideline domain Guideline Specification
Medication restriction Short-acting bronchodilators, 8h; long acting bronchodilators, 48h; 
cromolyn sodium, 8h; nedocromil, 48h; anti-histamines, 3d; 
leukotriene modifiers, 24 h.
Exercise intensity Monitored via heart rate (HR) or ventilation (VE). Target HR >80% 
of predicted max (220 – age in years). VE 40-60% of predicted max 
maximum voluntary ventilation (FEV1 x 35).
Exercise duration Total duration 6-8 minutes with 4-6 minutes at exercise intensity 
described above. 
Environmental conditions 
(inspired air)
A nose clip should be worn and inhaled water content <10mg/l or 
<25oC with <50% relative humidity. Alternatively, dry air delivered 
from medical grade compressed gas source.  
Post-challenge spirometry 
timings
Spirometry performed pre-test and at 5, 10, 15, 20 and 30 minutes 
post-exercise. 
FEV1, Forced Expiratory Volume in 1 second.
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Figure 1. Adherence to exercise bronchial provocation guideline specifications1,4
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